克霉唑结晶

Name: 克霉唑结晶
Brand: 济南圣和化工有限公司

CAS 23593-75-1C22H17ClN2MW 344.8

济南圣和化工主营供应克霉唑结晶（CAS 23593-75-1），归类于染料及颜料，分子式 C22H17ClN2，分子量 344.8。我们面向国内化工贸易与生产企业提供稳定的现货供应，报价响应快，支持对公转账并可开具增值税发票。

产品概览

CAS号	23593-75-1
分子式	C22H17ClN2
分子量	344.8
熔点	148
LogP	6.1
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	染料及颜料
类别	染料及颜料

应用领域

染料及颜料

该产品的下游应用集中在染料及颜料。不同客户工艺差异较大，我们支持按需提供样品与小批量试用。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

供应说明：克霉唑结晶常规包装为按订单/批次确认(不公开发布)，储存时应密封置于阴凉干燥处，避免与氧化剂混放。济南圣和化工有限公司支持国内物流发货，大货交期与运费以订单确认为准。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

选择济南圣和化工有限公司的理由：产品信息透明（含 CAS、分子式、理化参数）、报价响应快（一个工作日内）、单证齐全（COA/MSS/质检资料按需提供）、支持批量与长期协议供货。如需克霉唑结晶以外的配套原料，也欢迎一并列出需求清单。

常见问题

克霉唑结晶的 CAS 号是多少？

克霉唑结晶的 CAS 号为 23593-75-1。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

克霉唑结晶有什么用途？

主要应用于染料及颜料。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

clotrimazole crystalline · CAS 23593-75-1 · C22H17ClN2. UNII G07GZ97H65. Melting Point: 148; Melting Point: 147-149 °C; Melting Point: 148 °C.

Identification

CAS Registry Number	23593-75-1
PubChem CID	2812
Molecular formula	C22H17ClN2
IUPAC name	1-[(2-chlorophenyl)-diphenylmethyl]imidazole
UNII (FDA)	G07GZ97H65

Computed Descriptors

Molecular Weight	344.8
XLogP3	5
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	1
Rotatable Bond Count	4
Exact Mass	344.1080262
Monoisotopic Mass	344.1080262
Topological Polar Surface Area	17.8
Heavy Atom Count	25
Formal Charge	0

Physical & Chemical Properties

Melting Point	148
Melting Point	147-149 °C
Melting Point	148 °C
Solubility	0.49
LogP	6.1
LogP	4.75
Dissociation Constants	4.1
Formulations/Preparations	Mycelex 1% cream

Physical description & handling notes

Solid
Crystals
White to pale yellow crystalline powder
Odorless
SOL IN ACETONE, CHLOROFORM, ETHYL ACETATE; SLIGHTLY SOL IN WATER, BENZENE, TOLUENE
Freely soluble in alcohol; soluble in polyethylene glycol 400

Regulatory Status

Regulatory & Food Contact	CIR / INCI: Antimicrobial; Antidandruff
GHS notification summary	1.5% (3 / 196)

GHS Hazard Classification

GHS notification summary	1.5% (3 / 196)
Reported hazard statements	H302 (96.9%), H311 (17.9%), H315 (65.3%), H319 (74.5%), H361 (17.9%), H373 (17.9%), H400 (71.4%), H410 (72.4%)

This chemical does not meet GHS hazard criteria for 1.5% (3 of 196) of reports.

H302 (96.9%): Harmful if swallowed [Warning Acute toxicity, oral]

Documented Uses

Use (kg) in Switzerland (2009): >100
Use (kg; approx.) in Germany (2009): >2500
Consumption (g per capita) in Switzerland (2009): 0.013
Consumption (g per capita; approx.) in Germany (2009): 0.031
Consumption (g per capita) in the USA (2002): 0.0036
For the local treatment of oropharyngeal candidiasis and vaginal yeast infections, also used in fungal infections of the skin such as ringworm, athlete's foot, and jock itch.

Synonyms

clotrimazole; 23593-75-1; Lotrimin; Canesten; Mycosporin; Mycelex; Clotrimazol; Empecid; Mykosporin; Gyne lotrimin; Chlotrimazole; Trimysten; Gyne-Lotrimin; Mycelex G; Rimazole; Tibatin

Frequently Asked Questions

What are the CAS number and molecular formula of clotrimazole crystalline?

CAS 23593-75-1; molecular formula C22H17ClN2; molecular weight — g/mol.

What other names is clotrimazole crystalline known by?

clotrimazole, 23593-75-1, Lotrimin, Canesten, Mycosporin, Mycelex.

What is the regulatory status of clotrimazole crystalline?

Documented regulatory listings: CIR / INCI: Antimicrobial; Antidandruff.

Is clotrimazole crystalline classified as hazardous?

1.5% of GHS notifications report no hazard classification (3 of 196).

What are the key physical properties of clotrimazole crystalline?

Melting Point: 148; Melting Point: 147-149 °C; Melting Point: 148 °C; Solubility: 0.49.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.